<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:department>School of Life Sciences</gtr:department><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/990DB5C6-AAE7-42F3-8A96-028B2CC56F03"><gtr:id>990DB5C6-AAE7-42F3-8A96-028B2CC56F03</gtr:id><gtr:firstName>Juan</gtr:firstName><gtr:otherNames>F</gtr:otherNames><gtr:surname>Lopez-Gimenez</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/48C13E55-28C1-4AE4-BA67-521BE128FE74"><gtr:id>48C13E55-28C1-4AE4-BA67-521BE128FE74</gtr:id><gtr:firstName>Graeme</gtr:firstName><gtr:surname>Milligan</gtr:surname><gtr:orcidId>0000-0002-6946-3519</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FG001200%2F1"><gtr:id>14BC276E-DC05-4E88-B544-5168EE1F5BEB</gtr:id><gtr:title>Molecular basis of the functional regulation of mu opioid receptors by co-expressed Gq/G11-coupled GPCRs</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/G001200/1</gtr:grantReference><gtr:abstractText>Opioid alkaloids such as morphine and heroin are well known drugs of abuse. However, they are also highly effective analgesics. Morphine is the most effective analgesic for treatment of severe refractory pain. A major limitation in use of morphine in a clinical setting is that, over time, patients require higher and higher doses for effect. This is termed tolerance. If this could be prevented then morphine would be even more effective. Although the basis of tolerance is complex, one key element appears to be the lack of capacity of morphine to cause internalisation and desensitisation of its molecular target, the mu opioid receptor. A series of studies have suggested that if this could be achieved, tolerance would be limited or abolished. Using a model system we have shown that if the 5-HT2A receptor, a receptor that responds to the neurotransmitter serotonin and which is expressed in the same cells as the mu opioid receptor in a number of brain regions, is activated at the same time, morphine is now able to cause internalisation and desensitisation of the mu opioid receptor. We wish to explore the molecular basis of these observations and explore if they can be generalised to other co-expressed receptors.</gtr:abstractText><gtr:technicalSummary>Morphine is a highly effective, clinically employed analgesic. However, the development of tolerance to morphine with sustained treatment severely restricts its longer term use. Because morphine produces little internalisation of its molecular target, the mu opioid receptor, it has been suggested that a lack of mu opioid receptor desensitisation, internalisation and recycling to the cell surface is integral to development of tolerance. Many G protein-coupled receptors are co-expressed in specific neurones and co-activation can modulate their actions. We have generated substantial preliminary data that morphine can cause highly efficient internalisation and desensitisation of the mu opioid receptor when a co-expressed 5-HT2A receptor is activated in parallel and that this effect requires activation of Gq/11-dependent signalling pathways. We plan to explore the molecular basis of these observations because our preliminary data indicate that it is clealry more complex than 5-HT2A receptor-mediated activation of protein kinase C resulting in direct phosphorylation of the mu opioid receptor. We also wish to ascertain whether such an effects are restricted to the 5-HT2A receptor or canm be mimicked by other Gq/11/linked G protein-coupled receptors that are known to be co-expressed with the mu opioid receptor. We will then expand these studies to determine if the observations can be reproduced in a neuronal cell model system that expresses the mu opioid receptor endogenously and in which we have performed a genome-wide G protein-coupled receptor screen to identify the expression pattern of Gq/11-coupled G protein-coupled receptors.</gtr:technicalSummary><gtr:fund><gtr:end>2011-11-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>441022</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/834E7FD7-D24D-45F7-8AD7-FC88A6F99B01"><gtr:id>834E7FD7-D24D-45F7-8AD7-FC88A6F99B01</gtr:id><gtr:title>Opioid regulation of Mu receptor internalisation: relevance to the development of tolerance and dependence</gtr:title><gtr:parentPublicationTitle>CNS and Neurological Disorders: Drug Targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6e4ac0b35bc1f3ec96a4d004b2ee4f6e"><gtr:id>6e4ac0b35bc1f3ec96a4d004b2ee4f6e</gtr:id><gtr:otherNames>J.F. Lopez-Gimenez (Co-author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:isbn>1871-5273</gtr:isbn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1A57A33B-B2C1-40FF-84F2-1EAEA9F217FD"><gtr:id>1A57A33B-B2C1-40FF-84F2-1EAEA9F217FD</gtr:id><gtr:title>The other side of opioid receptor signalling: regulation by protein-protein interaction.</gtr:title><gtr:parentPublicationTitle>Current drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/41e0a5e99447165032db97d2b0b639f3"><gtr:id>41e0a5e99447165032db97d2b0b639f3</gtr:id><gtr:otherNames>Georgoussi Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1389-4501</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/49F07A7C-3FD3-4A58-80E6-F2C43EA015AF"><gtr:id>49F07A7C-3FD3-4A58-80E6-F2C43EA015AF</gtr:id><gtr:title>Opioid Regulation of Mu Receptor Internalisation: Relevance to the Development of Tolerance and Dependence</gtr:title><gtr:parentPublicationTitle>CNS &amp; Neurological Disorders - Drug Targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f7fe59f80acf6b0a83feb710899a6a20"><gtr:id>f7fe59f80acf6b0a83feb710899a6a20</gtr:id><gtr:otherNames>F. Lopez-Gimenez J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0660AE7A-53A1-4470-9D5B-C5FE5A6A0B31"><gtr:id>0660AE7A-53A1-4470-9D5B-C5FE5A6A0B31</gtr:id><gtr:title>Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/007b27bf0d80b1a0eb2b339032484e9c"><gtr:id>007b27bf0d80b1a0eb2b339032484e9c</gtr:id><gtr:otherNames>Lopez-Gimenez JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7DCF63E8-44DB-44AF-AA04-DF8B14AF495E"><gtr:id>7DCF63E8-44DB-44AF-AA04-DF8B14AF495E</gtr:id><gtr:title>Opioid regulation of mu receptor internalisation: relevance to the development of tolerance and dependence.</gtr:title><gtr:parentPublicationTitle>CNS &amp; neurological disorders drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/007b27bf0d80b1a0eb2b339032484e9c"><gtr:id>007b27bf0d80b1a0eb2b339032484e9c</gtr:id><gtr:otherNames>Lopez-Gimenez JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1871-5273</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/G001200/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>